Active, Not Recruiting
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
NCT04929392
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +31 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States